Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001000694-23-000027
Filing Date
2023-04-28
Accepted
2023-04-28 16:36:09
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A novavaxinc2023defa14a.htm DEFA14A 12475
2 novavaxinc_p92816xp92738001.jpg GRAPHIC 146570
3 novavaxinc_p92816xp92738002.jpg GRAPHIC 145599
  Complete submission text file 0001000694-23-000027.txt   416014
Mailing Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

EIN.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26770 | Film No.: 23867233
SIC: 2836 Biological Products, (No Diagnostic Substances)